Smiths Group, the FTSE100 engineering conglomerate, has received a £2.0bn takeover offer from US private equity firm TA Associates for its medical division, according to reports.
Talks are understood to be at an advanced stage, the Mail on Sunday reported, citing “City sources”, although a price has yet to be agreed. Earlier in the year, the two groups failed to reach an agreement on the price, the paper said.
Free Webinar: Personalizing One to Many: Investor Relations at Scale
- What are the best practices for investor relationships when the number of fund and LP’s increase
- How has technology reshaped investor relationship management?
- What are the most important factors for LP’s when deciding where to place their funds now and in the future?
Smiths, one of the UK’s last industrial conglomerates, has been looking to spin off its struggling medical products division since the end of 2018 and in March 2019 said it was looking to list it as a separate company on the London Stock Exchange.
This March, the group announced that the planned demerger of the medical arm remained on track for the end of 2021, with the potential alternative of a UK listing.
Analysts at broker Peel Hunt said: “We await confirmation from the company on the path forward, however would expect market interest in Smiths to improve following any such separation, which would leave a more focused business centred around high-quality industrial technologies.”
Source: Proactive Investors
Can’t stop reading? Read more
DWS outlines $6tn investment need in European infrastructure, positioning mid-cap strategy as core to long-term resilience
DWS outlines $6tn investment need in European infrastructure, positioning mid-cap strategy as core...
Top private equity news of the week
Top private equity news of the week Apollo Global Management is in advanced discussions to acquire...
Fund Friday: Top fundraising news in private equity
Fund Friday: Top fundraising news in private equity Neuberger Berman has held the final close of...